申请人:Janssen Pharmaceuticals, Inc.
公开号:US10155727B2
公开(公告)日:2018-12-18
The invention relates to pyrazole derivatives which are NMDA NR2B receptor inhibitors, useful in treating central nervous system diseases.
本发明涉及
吡唑衍
生物,它们是 N
MDA NR2B 受体
抑制剂,可用于治疗中枢神经系统疾病。